10 likes | 429 Views
Figure 2 Ongoing phase III clinical trials of PCSK9 inhibitors. Dadu, R. T. & Ballantyne, C. M. (2014) Lipid lowering with PCSK9 inhibitors Nat. Rev. Cardiol. doi:10.1038/nrcardio.2014.84.
E N D
Figure 2 Ongoing phase III clinical trials of PCSK9 inhibitors Dadu, R. T. & Ballantyne, C. M. (2014) Lipid lowering with PCSK9 inhibitors Nat. Rev. Cardiol. doi:10.1038/nrcardio.2014.84